VEGFA and diabetic retinopathy: ALA has been shown to possess cytoprotective and neuroprotective properties, notably reducing inflammatory mediators, such as VEGF and pro-inflammatory cytokines (IL-6, IL-1β, TNF-α), in diabetic retinopathy models [54].